144 related articles for article (PubMed ID: 27125717)
1. Mesalamine Does Not Help Prevent Recurrent Acute Colonic Diverticulitis: Meta-Analysis of Randomized, Placebo-Controlled Trials.
Khan MA; Ali B; Lee WM; Howden CW
Am J Gastroenterol; 2016 Apr; 111(4):579-81. PubMed ID: 27125717
[No Abstract] [Full Text] [Related]
2. Mesalazine in preventing acute diverticulitis occurrence: a meta-analysis of randomized controlled trials.
Tursi A; Picchio M
J Gastrointestin Liver Dis; 2016 Sep; 25(3):409-11. PubMed ID: 27689212
[No Abstract] [Full Text] [Related]
3. Mesalazine to treat symptomatic uncomplicated diverticular disease and to prevent acute diverticulitis occurrence. A systematic review with meta-analysis of randomized, placebo-controlled trials.
Picchio M; Elisei W; Tursi A
J Gastrointestin Liver Dis; 2018 Sep; 27(3):291-297. PubMed ID: 30240473
[TBL] [Abstract][Full Text] [Related]
4. Effect of mesalazine on recurrence of diverticulitis in patients with symptomatic uncomplicated diverticular disease: a meta-analysis with trial sequential analysis of randomized controlled trials.
Khan RMA; Ali B; Hajibandeh S; Hajibandeh S
Colorectal Dis; 2018 Jun; 20(6):469-478. PubMed ID: 29520987
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled study of mesalamine after acute diverticulitis: results of the DIVA trial.
Stollman N; Magowan S; Shanahan F; Quigley EM;
J Clin Gastroenterol; 2013 Aug; 47(7):621-9. PubMed ID: 23426454
[TBL] [Abstract][Full Text] [Related]
6. Mesalazine for the Treatment of Symptomatic Uncomplicated Diverticular Disease of the Colon and for Primary Prevention of Diverticulitis: A Systematic Review of Randomized Clinical Trials.
Picchio M; Elisei W; Brandimarte G; Di Mario F; Malfertheiner P; Scarpignato C; Tursi A
J Clin Gastroenterol; 2016 Oct; 50 Suppl 1():S64-9. PubMed ID: 27622370
[TBL] [Abstract][Full Text] [Related]
7. Medical treatment of colonic diverticular disease: are we sure the aim is right?
Bassotti G; Villanacci V
Intern Emerg Med; 2012 Apr; 7(2):97-8. PubMed ID: 21424908
[No Abstract] [Full Text] [Related]
8. Therapeutic management of acute uncomplicated diverticulitis.
Fan YC; Peery AF
Minerva Gastroenterol Dietol; 2017 Jun; 63(2):143-151. PubMed ID: 27990793
[TBL] [Abstract][Full Text] [Related]
9. Treatment of diverticular disease of the colon and prevention of acute diverticulitis: a systematic review.
Maconi G; Barbara G; Bosetti C; Cuomo R; Annibale B
Dis Colon Rectum; 2011 Oct; 54(10):1326-38. PubMed ID: 21904150
[TBL] [Abstract][Full Text] [Related]
10. New medical strategies for the management of acute diverticulitis.
Tursi A
Expert Rev Gastroenterol Hepatol; 2015; 9(10):1293-304. PubMed ID: 26289102
[TBL] [Abstract][Full Text] [Related]
11. Mesalamine did not prevent recurrent diverticulitis in phase 3 controlled trials.
Raskin JB; Kamm MA; Jamal MM; Márquez J; Melzer E; Schoen RE; Szalóki T; Barrett K; Streck P
Gastroenterology; 2014 Oct; 147(4):793-802. PubMed ID: 25038431
[TBL] [Abstract][Full Text] [Related]
12. Preventive therapy for complicated diverticular disease of the colon: looking for a correct therapeutic approach.
Tursi A
Gastroenterology; 2004 Dec; 127(6):1865-6. PubMed ID: 15578538
[No Abstract] [Full Text] [Related]
13. Treatment of Diverticular Disease With Aminosalicylates: The Evidence.
Barbara G; Cremon C; Barbaro MR; Bellacosa L; Stanghellini V
J Clin Gastroenterol; 2016 Oct; 50 Suppl 1():S60-3. PubMed ID: 27622369
[TBL] [Abstract][Full Text] [Related]
14. Mesalamine in Recurrent Acute Colonic Diverticulitis.
Dai C; Jiang M; Sun MJ
Am J Gastroenterol; 2016 Nov; 111(11):1656-1657. PubMed ID: 27808151
[No Abstract] [Full Text] [Related]
15. The metabolism of mesalamine and its possible use in colonic diverticulitis as an anti-inflammatory agent.
Cohen HD; Das KM
J Clin Gastroenterol; 2006 Aug; 40 Suppl 3():S150-4. PubMed ID: 16885699
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of different therapeutic strategies in preventing diverticulitis recurrence.
Tursi A; Elisei W; Giorgetti GM; Inchingolo CD; Nenna R; Picchio M; Maiorano M; Penna A; Lecca PG; Brandimarte G
Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):342-8. PubMed ID: 23426537
[TBL] [Abstract][Full Text] [Related]
17. Mesalamine (5-ASA) for the prevention of recurrent diverticulitis (Review).
Carabotti M; Annibale B
Tech Coloproctol; 2019 Jun; 23(6):597-599. PubMed ID: 31346815
[No Abstract] [Full Text] [Related]
18. Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon.
Tursi A; Brandimarte G; Daffinà R
Dig Liver Dis; 2002 Jul; 34(7):510-5. PubMed ID: 12236485
[TBL] [Abstract][Full Text] [Related]
19. Use of mesalazine in diverticular disease.
Di Mario F; Comparato G; Fanigliulo L; Aragona G; Cavallaro LG; Cavestro GM; Franzé A
J Clin Gastroenterol; 2006 Aug; 40 Suppl 3():S155-9. PubMed ID: 16885700
[TBL] [Abstract][Full Text] [Related]
20. Aminosalicylates.
Gross V
Dig Dis; 2012; 30(1):92-9. PubMed ID: 22572694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
